HealthCCSng vs ClearRead CT

Direct competitors — feature-level head-to-head below. Comparability 85/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Nano-X AI
VS
by RIVERAIN TECHNOLOGIES

AI Verdict

HealthCCSng is a specialized AI solution focused exclusively on detecting and quantifying coronary artery calcification from routine CT scans. ClearRead CT also offers coronary artery calcification scoring but expands its capabilities significantly to include comprehensive pulmonary nodule detection, characterization, and tracking. Therefore, while both tools directly compete in the domain of CAC analysis, ClearRead CT provides a broader cardiothoracic AI suite.

Choose HealthCCSng if…

Choose HealthCCSng if your primary objective is a dedicated, automated, and precise assessment of coronary artery calcification (CAC) from routine, non-gated, non-contrast CT scans. This tool is ideal for opportunistically identifying patients at risk of coronary artery disease through detailed quantification, categorization (including a 'zero' CAC category), and numerical scoring of CAC, without requiring additional imaging protocols.

View HealthCCSng →

Choose ClearRead CT if…

Choose ClearRead CT if your practice requires a versatile AI solution for comprehensive cardiothoracic imaging analysis, encompassing both pulmonary nodule detection and coronary artery calcification (CAC) scoring. This tool is particularly beneficial for improving diagnostic accuracy, reducing reading times, and streamlining workflows across a broader range of cardiothoracic conditions, leveraging features like patented vessel suppression, automated nodule tracking, and volumetric measurements.

View ClearRead CT →

When choosing between HealthCCSng and ClearRead CT, physicians should consider their primary diagnostic focus. HealthCCSng excels in dedicated coronary artery calcification (CAC) analysis, automatically detecting and quantifying CAC from routine CT scans and categorizing risk. It provides a numerical calcium score and visualizes calcified plaques, integrating seamlessly into existing PACS and EMR systems for an automated workflow. This tool is best suited for cardiologists or radiologists whose primary need is a robust, streamlined solution for cardiovascular risk assessment based on CAC.

In contrast, ClearRead CT offers a broader AI suite for cardiothoracic health, combining CAC analysis with advanced pulmonary nodule detection and characterization. Its key practical difference lies in its patented vessel suppression technology and comprehensive nodule features, including automated tracking and comparison to prior exams. While it also performs CAC scoring on ungated, non-contrast CTs, its strength lies in improving diagnostic accuracy and reducing reading times for pulmonary nodules. Therefore, ClearRead CT is ideal for radiologists or pulmonologists who require a versatile tool addressing both cardiovascular risk and, more significantly, lung nodule management within a single platform.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature HealthCCSng ClearRead CT
Pricing Not publicly available Contact for pricing
Deployment Cloud-based, integrates with PACS and EMR systems On-premise (stand-alone server, virtual machine) and Cloud
FDA Status Yes AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature HealthCCSng ClearRead CT
Name HealthCCSng ClearRead CT
Company Nano-X AI RIVERAIN TECHNOLOGIES
Primary AI Focus Coronary artery calcification detection and quantification from routine CT scans. Enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans.
Coronary Artery Calcification (CAC) Analysis Analyzes non-contrast, non-ECG gated chest CT scans; automatically detects and quantifies CAC; categorizes studies into 'zero', 'low', 'moderate', and 'severe' CAC categories; generates a numerical calcium score; provides visualization of calcified plaques. Coronary Artery Calcification (CAC) Scoring (ungated, non-contrast CTs).
Pulmonary Nodule Detection Not specified Detects solid, part-solid, ground glass nodules; provides characterization, measurement (volume, diameter, location, type, depth); automated tracking and comparison to prior exams; patented Vessel Suppression (Clear Visual Intelligence).
Integration Seamless integration with PACS and EMR systems Seamless PACS Integration / Vendor-neutral processing

Videos

Demos, reviews, and walkthroughs featuring HealthCCSng and ClearRead CT.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

HealthCCSng is an AI-powered solution focused on automatically detecting and quantifying coronary artery calcification (CAC) from routine CT scans to identify patients at risk of coronary artery disease. ClearRead CT, while also offering coronary artery calcification analysis, provides a broader suite of AI tools for cardiothoracic health, including comprehensive pulmonary nodule detection, characterization, and tracking in CT scans.
HealthCCSng provides an automated workflow for generating CAC results without human intervention and customizable CAC category configurations. ClearRead CT features patented vessel suppression technology, automated nodule tracking and comparison to prior exams, and aims to reduce reading times and improve nodule detection accuracy.
HealthCCSng is primarily aimed at Cardiology and Radiology specialties, focusing on cardiovascular risk assessment. ClearRead CT supports Cardiology and Radiology, and also extends its utility to Pulmonology due to its robust pulmonary nodule detection features.
Yes, both HealthCCSng and ClearRead CT are designed to detect and quantify coronary artery calcification from ungated, non-contrast chest CT scans. This allows for opportunistic screening from routine scans.
HealthCCSng emphasizes an automated workflow that analyzes DICOM studies and provides results without human intervention. ClearRead CT highlights benefits such as a reported 26% reduction in reading time for nodule searches and a 29% reduction in missed actionable nodules.
AI Tool Finder
AI-powered search. Results may not be comprehensive.